Increased ASAP1 expression in different types of cancer, including colon cancer, head and neck squamous cell carcinoma, epithelial ovarian cancer, renal cancer, pancreas cancer, gastric cancer, and triple-negative breast cancer, was associated with poor prognosis and aggressive clinical features (12-20). Here, ASAP1 is linked to renal carcinoma.